Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/24737
Title: Improved Respiratory Outcomes for X-Linked Myotubular Myopathy (XLMTM) with Gene Replacement Therapy, Resamirigene Bilparvovec (ASPIRO): Preliminary Results from ASPIRO, a Phase 1/2/3 Study
Authors: Perez, GF
Shieh, P
Kuntz, N
Dowling, J
Mueller-Felber, W
Blaschek, A
Bonnemann, C
Foley, A
Saade, D
Seferian, A
Servais, L
Lawlor, M
MacBean, V
Coats, J
Han, C
Lee, J
Noursalehi, M
Prasad, S
Rico, S
Miller, W
Graham, R
Issue Date: 1-May-2022
Citation: Perez, G.F., Shieh, P., Kuntz, N., Dowling, J.J., Müller-Felber, W., Blaschek, A., Bönnemann, C., Foley, A.R., Saade, D., Seferian, A.M.S., Servais, V., Lawlor, M., MacBean, V., Coats J.,Han C., Lee J., Noursalehi M., Prasad S., Rico, S., Miller, W. and Graham, R.J. (2022) 'Improved Respiratory Outcomes for X-Linked Myotubular Myopathy (XLMTM) with Gene Replacement Therapy, Resamirigene Bilparvovec (ASPIRO): Preliminary Results from ASPIRO, a Phase 1/2/3 Study', American Journal of Respiratory and Critical Care Medicine, 205, A3003, pp. 1-3. doi: 10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3003.
URI: https://bura.brunel.ac.uk/handle/2438/24737
DOI: https://doi.org/10.1164/ajrccm-conference.2022.205.1_MeetingAbstracts.A3003
ISSN: 1073-449X
Other Identifiers: A3003
Appears in Collections:Dept of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
MeetingAbstract.pdf129.71 kBAdobe PDFView/Open


Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.